In our opinion, these findings offer new biological and mechanistic insights into the mechanism(s) underlying FoxO1 gene regulation and might be useful in understanding the molecular basis of clinical phenotypes in those conditions where insulin action is compromised (e.g., T2D and other insulin-resistant states). Here, INS is linked to type 2 diabetes mellitus.